Jannet Blom

777 total citations
14 papers, 466 citations indexed

About

Jannet Blom is a scholar working on Genetics, Oncology and Molecular Biology. According to data from OpenAlex, Jannet Blom has authored 14 papers receiving a total of 466 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Genetics, 4 papers in Oncology and 3 papers in Molecular Biology. Recurrent topics in Jannet Blom's work include BRCA gene mutations in cancer (11 papers), DNA Repair Mechanisms (3 papers) and Global Cancer Incidence and Screening (2 papers). Jannet Blom is often cited by papers focused on BRCA gene mutations in cancer (11 papers), DNA Repair Mechanisms (3 papers) and Global Cancer Incidence and Screening (2 papers). Jannet Blom collaborates with scholars based in Netherlands, United States and United Kingdom. Jannet Blom's co-authors include Caroline Seynaeve, Mieke Kriege, Mano Swartz, Cecile T.M. Brekelmans, Hanne Meijers-Heijboer, Madeleine M.A. Tilanus‐Linthorst, Maartje J. Hooning, Agnes Jager, Jan G.M. Klijn and J.G.M. Klijn and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Annals of Oncology.

In The Last Decade

Jannet Blom

14 papers receiving 449 citations

Peers

Jannet Blom

GENET

MB

ONCOL

CR

OPHTH

Mariëlle Ruijs Netherlands

Claude Houdayer France

Marie Janson Sweden

S. Gayther United Kingdom

Maran J.W. Olderode-Berends Netherlands

Elena Lang Switzerland

Masaaki Nagatake Japan

Jeffrey S. Skilling United States

Hiroaki Yamaoka Japan

Barbara Bulman United Kingdom

Mariëlle Ruijs Netherlands

Jannet Blom

135 ×0.4

GENET

209 ×1.1

MB

207 ×1.2

ONCOL

108 ×0.7

CR

4 ×0.1

OPHTH

Citations per year, relative to Jannet Blom Jannet Blom (= 1×) peers Mariëlle Ruijs

Countries citing papers authored by Jannet Blom

Since Specialization

Citations

This map shows the geographic impact of Jannet Blom's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jannet Blom with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jannet Blom more than expected).

Fields of papers citing papers by Jannet Blom

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jannet Blom. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jannet Blom. The network helps show where Jannet Blom may publish in the future.

Co-authorship network of co-authors of Jannet Blom

This figure shows the co-authorship network connecting the top 25 collaborators of Jannet Blom. A scholar is included among the top collaborators of Jannet Blom based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jannet Blom. Jannet Blom is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

1.

Kriege, Mieke, Agnes Jager, Antoinette Hollestelle, et al.. (2015). Sensitivity to systemic therapy for metastatic breast cancer in CHEK2 1100delC mutation carriers. Journal of Cancer Research and Clinical Oncology. 141(10). 1879–1887. 8 indexed citations

2.

Huijts, Petra E.A., Antoinette Hollestelle, Brunilda Balliu, et al.. (2013). CHEK2*1100delC homozygosity in the Netherlands—prevalence and risk of breast and lung cancer. European Journal of Human Genetics. 22(1). 46–51. 31 indexed citations

3.

Kriege, Mieke, Agnes Jager, Maartje J. Hooning, et al.. (2011). The efficacy of taxane chemotherapy for metastatic breast cancer in BRCA1 and BRCA2 mutation carriers. Cancer. 118(4). 899–907. 67 indexed citations

4.

Kriege, Mieke, Caroline Seynaeve, Hanne Meijers-Heijboer, et al.. (2009). Sensitivity to First-Line Chemotherapy for Metastatic Breast Cancer in BRCA1 and BRCA2 Mutation Carriers. Journal of Clinical Oncology. 27(23). 3764–3771. 77 indexed citations

5.

Bock, Geertruida H. de, Catharina E. Jacobi, Caroline Seynaeve, et al.. (2008). A family history of breast cancer will not predict female early onset breast cancer in a population-based setting. BMC Cancer. 8(1). 203–203. 10 indexed citations

6.

Huijts, Petra E.A., Maaike P.G. Vreeswijk, Catharina E. Jacobi, et al.. (2007). Clinical correlates of low-risk variants in FGFR2, TNRC9, MAP3K1, LSP1 and 8q24 in a Dutch cohort of incident breast cancer cases. Breast Cancer Research. 9(6). R78–R78. 59 indexed citations

7.

Bock, Geertruida H. de, M J E Mourits, Mieke Schutte, et al.. (2006). Association between the CHEK2*1100delC germ line mutation and estrogen receptor status. International Journal of Gynecological Cancer. 16(s2). 552–555. 17 indexed citations

8.

Brekelmans, Cecile T.M., Caroline Seynaeve, M. Menke-Pluymers, et al.. (2005). Survival and prognostic factors in BRCA1-associated breast cancer. Annals of Oncology. 17(3). 391–400. 101 indexed citations

9.

Seynaeve, Caroline, Madeleine M.A. Tilanus‐Linthorst, Hanne Meijers-Heijboer, et al.. (2004). BRCA1- versus non-BRCA1/2-associated breast cancer (BC): Tumor characteristics and impact of prognostic and treatment factors. Journal of Clinical Oncology. 22(14_suppl). 9557–9557. 1 indexed citations

10.

Seynaeve, Caroline, Madeleine M.A. Tilanus‐Linthorst, Hanne Meijers-Heijboer, et al.. (2004). BRCA1- versus non-BRCA1/2-associated breast cancer (BC): Tumor characteristics and impact of prognostic and treatment factors. Journal of Clinical Oncology. 22(14_suppl). 9557–9557. 1 indexed citations

11.

Asperen, C. J. van, Rob A.�E.�M. Tollenaar, Jannet Blom, et al.. (2003). Possible consequences of applying guidelines to healthy women with a family history of breast cancer. European Journal of Human Genetics. 11(8). 633–636. 9 indexed citations

12.

Swartz, Mano, et al.. (1981). Tamoxifen retinopathy.. British Journal of Ophthalmology. 65(3). 177–179. 75 indexed citations

13.

Bergevin, Patrick R., D C Tormey, & Jannet Blom. (1972). Guide to the use of cancer chemotherapeutic agents.. PubMed. 9(2). 185–273. 4 indexed citations

14.

Jones, B, Janet Cuttner, RN Levy, et al.. (1972). Daunorubicin (NSC-83142) versus daunorubicin plus prednisone (NSC-10023) versus daunorubicin plus vincristine (NSC-67574) plus prednisone in advanced childhood acute lymphocytic leukemia.. PubMed. 56(6). 729–37. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact